Chemokines in the resolution of inflammation: key players and targets for therapeutic modulation. [PDF]
Oliveira VLS, Proost P, Struyf S.
europepmc +1 more source
Chemokine CXC motif ligand 12 (CXCL12; SDF-1); CXC chemokine receptor 4 (CXCR4; NPY3R) [PDF]
openaire +1 more source
Extended repertoire of CXC chemokines acting as agonists and antagonists of the human and murine atypical chemokine receptor ACKR2. [PDF]
Luís R +3 more
europepmc +1 more source
The role of CXC chemokines and receptors in breast cancer. [PDF]
Masrour M +4 more
europepmc +1 more source
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005). [PDF]
Jin HY.
europepmc +1 more source
CXC chemokine receptor 4 (CXCR4; NPY3R); chemokine CXC motif ligand 12 (CXCL12; SDF-1) [PDF]
openaire +1 more source
Engineered Macrophage Membrane-Coated Nanoparticles for Hepatic Ischemia-Reperfusion Injury Therapeutics. [PDF]
Yang L +13 more
europepmc +1 more source
Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network. [PDF]
Kleist AB +16 more
europepmc +1 more source
CXCL3 promotes liver cancer progression by modulating the tumor microenvironment via the PI3K/AKT/mTOR pathway. [PDF]
Li Y +9 more
europepmc +1 more source
Chemokine CXC motif ligand 12 (CXCL12; SDF-1); CXC chemokine receptor 4 (CXCR4; NPY3R) [PDF]
openaire +1 more source

